搜索优化
English
网页
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按相关度排序
按时间排序
Medscape
1 天
MRI Before Surgery Reduces Treatment Time for Muscle Invasive Bladder Cancer
Patients with suspected new bladder cancer were randomly assigned 1:1 to transurethral resection of bladder tumor or ...
5 天
on MSN
Bladder cancer: Symptoms to look out for and when to see a doctor
Symptoms to look out for and when to see a doctor - There are roughly 10,000 people a year diagnosed with bladder cancer in ...
1 天
ImmunityBio: Making Its Next Strikes After Bladder Cancer Approval
ImmunityBio, Inc.'s Anktiva shows promise for solid tumors, with growing sales and financing boosting growth potential. Click ...
3 天
on MSN
Experts hail bladder cancer drug 'breakthrough'
Medical experts in Sheffield have hailed as a "game changer" trials of a drug that could reduce the recurrence of bladder ...
6 天
on MSN
‘Increased survival rates’ for bladder cancer patients given immunotherapy drug
Overall survival at two years was 82.2% in the durvalumab group and 75.2% in the comparator group. Durvalumab (brand name ...
6 天
Lung cancer drug already available on NHS could cut bladder deaths
A lung cancer drug already available on the NHS has been proven to cut bladder cancer deaths and reduce the risk of the ...
3 天
on MSN
Most common symptom of bladder cancer to watch out for
They hope it will be approved by the Medicines and Healthcare Products Regulatory Agency to become the new standard of care.
The Independent on MSN
6 天
‘Game changer’ immunotherapy drug could lead to increased survival rates for bladder ...
The study found that patients with muscle-invasive bladder cancer had significantly less risk of cancer progressing or ...
GlobalData on MSN
5 天
Pfizer’s Phase III bladder cancer therapy trial meets primary endpoint
The trial showed a 'clinically meaningful' and 'statistically significant' improvement when treated with therapy plus BCG, ...
Cure Today
5 天
Sasanlimab Improves Event-Free Survival for Some With Bladder Cancer
The investigational anti-PD-1 monoclonal antibody is showing positive topline results from the phase 3 CREST trial.
News Medical on MSN
3 天
PIN1 protein found to be a significant driver of bladder cancer
Like all cancers, bladder cancer develops when abnormal cells start to multiply out of control. But what if we could put a ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈